Bahija Jallal
CEO & Executive DirectorDr. Bahija Jallal, Ph.D. served as Director of Outpace Bio, Inc. She serves as Chief Executive Officer and Director of Immunocore Holdings plc (formerly known as Immunocore Holdings Limited) since January 4, 2019. Dr. Bahija Jallal serves as Member of Scientific Advisory Board at Cullinan Therapeutics, Inc. (formerly known as Cullinan Oncology, Inc.) since June 2023. She serves as an Independent Director at ArriVent Biopharma, Inc. since February 2022. Dr. Jallal was Chair of Board of Directors at Viela Bio, Inc. Dr. Jallal has been an Independent Director at Elevance Health Inc. (formerly known as Anthem, Inc.) since February 1, 2018. From October 2013 to January 2019, she served as Executive Vice President of AstraZeneca PLC and President of MedImmune, a subsidiary of AstraZeneca since January 2013 to January 2019. She led the development and approval of five new biologic medicines across three therapeutic areas, while boosting the company?s research & development pipeline and deal-making. She held various research and development positions at MedImmune, including Senior Vice President, Research and Development from 2010 to 2013. Dr. Jallal served as Senior Vice President of Research & Development at Medimmune LLC. She served as Vice President of Translational Sciences at Medimmune LLC since March 2006. She served as a Member of AstraZeneca plc?s senior executive team from 2008 to 2019. She joined MedImmune in 2006 from Chiron Corporation where she served as Vice President, drug assessment and development. She served as Vice President of Translational Medicine Group at Novartis/ Chiron. She has R&D and leadership experience and expertise in the biopharmaceutical industry. Previously, she served at Sugen, Inc. She serves as Director at UMB Health Sciences Research Park Corporation. Dr. Jallal has served as the Chief Executive Officer of Immunocore Limited, a T cell receptor biotechnology company, since January 2019. She serves as a Member of Scientific Advisory Board at Predictive Biomarker Sciences, Inc. Dr. Jallal is also a Council Member of the Government-University-Industry Research Roundtable of the National Academies of Sciences, Engineering and Medicine. She served as Non-Executive Director of ADC Therapeutics SA. She is a Member of the National Science Foundation. She was the President of the Board of Directors of the Association for Women in Science since 2016 until 2018 and is also on the Board of Trustees of the Johns Hopkins University since 2014. She conducted her postdoctoral research at the Max Planck Institute of Biochemistry in Martinsried, Germany. She is a Member of the Board of Directors of University of Maryland Health Sciences Research Park Corporation. She was Independent Director of Guardant Health, Inc. since April 17, 2019 until June 15, 2022. Dr. Jallal has authored more than 70 peer-reviewed publications and holds more than 15 patents. She received her Ph.D. degree in physiology and DEA degree in physiology and biology from the Universite de Paris VI and her AEA degree in plant physiology and M.S. degree in biology from the Universite de Paris VII.
Positions
- Company NameImmunocore Holdings plcStock CodeIMCRPositionCEO & Executive DirectorColleagues
- BJBahija JallalCEO & Executive Director
- JIJohn Irving BellIndependent Non-Executive Chairman
- TATravis Alan CoyCFO, Executive VP & Head of Corporate Development
- KRKripa RamExecutive VP & Chief Operating Officer
- JGJohn GollSVP, Finance & Chief Accounting Officer
- AVAnnelise VuidepotChief Science and Technology Officer & Milton Park Site Head
- KPKristine PetersonIndependent Non-Executive Director
- SKSiddharth KaulIndependent Non-Executive Director
- PJPeter John RatcliffeIndependent Non-Executive Director
- Company NameElevance Health, Inc.Stock CodeELVPositionIndependent DirectorColleagues
- GKGail Koziara BoudreauxPresident, CEO & Director
- RGRamiro G. PeruIndependent Chair of the Board
- MBMark Bradley KayeExecutive VP & CFO
- PDPeter David HaytaianSpecial Advisor
- CMCharles Morgan KendrickEVP and President of Commercial & Specialty Health Benefits
- FFFelicia Farr NorwoodExecutive VP & Chief Health Benefits Officer
- AFAntonio Fabio NeriIndependent Director
- RMRyan M. SchneiderIndependent Director
